focus -WSS

focus

author：hotspot 2025-10-01 02:12:30 - browse：5473

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA drug safety: Singulair case shows systemic surveillance flaws

explore

WSS

Virtual care provider acquires bankrupt Pear's prescription apps

HCA sued by state AG for quality issues at Mission Health

The real point of Kenneth Smith’s execution by nitrogen gas

Grail spinoff by Illumina should end disastrous merger attempt

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Virtual care provider acquires bankrupt Pear's prescription apps

knowledge

focus

focus

Continuity nursing helped my family in our darkest PICU moments

What we need to know about Arena Bioworks

Hepatitis C has a cure — but many Americans still lack access to it

Medicare drug price negotiation hasn't dried up venture capital

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

In Spain, a hospital brews its own CAR

Activists slam private health insurers over coverage restrictions

Medicare drug price negotiation’s day in court

Virginia high school admissions case could be legal follow

What we need to know about Arena Bioworks

focus

SEC charges former device maker CEO with $41 million fraud

In Spain, a hospital brews its own CAR

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Commercial surrogacy can be ethical, despite pope’s claims

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Christmas in the PICU brings some surprising joy

hotspot

Wikipedia

explore

leisure time